IGM Biosciences to Present at Three Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: Nov 4, 2024
MOUNTAIN VIEW, Calif., Nov. 04, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will present at three upcoming investor conferences:
Read more at globenewswire.com
